Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_assertion description "[Our findings underscore the existence of a molecular interplay between LKB1-AMPK-mTORC1 and ErbB2-AKT-mTORC2 pathways with mTOR at its epicenter, suggestive that loss of LKB1 expression may serve as a marker for hyperactivated mTOR in HER2 positive breast cancer and warranting further investigation into therapeutics that target LKB1-AMPK-mTOR and glycolytic pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_assertion evidence source_evidence_literature NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_assertion SIO_000772 23451056 NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_assertion wasDerivedFrom befree-2016 NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_assertion wasGeneratedBy ECO_0000203 NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.
- befree-2016 importedOn "2016-02-19" NP1056921.RAHM-grBjifqVZDW31GNePLo4ItRNGdr0gA4MYKHsq2hE130_provenance.